Deven Willardson
Nurse Practitioner · Idaho Falls, IDNPI 1376033456
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Nalu Medical, Inc. at 39.1% of the total. 2025 is the largest year on record at $3,670, more than ten times the $203 reported in 2021. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $36.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$4K
- Abbott$3K
- Boston Scientific$2K
- AbbVie$665
- Medtronic$641
- Nevro Corp.$87
- plus $125 from 6 others
What the payments were for
- Consulting fees$1,80518%
- Travel & lodging$3,07631%
- Food & beverage$5,09951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 63 | $3,903 |
| Abbott | 37 | $2,618 |
| Boston Scientific | 58 | $1,940 |
| AbbVie | 40 | $665 |
| Medtronic | 64 | $641 |
| Nevro Corp. | 1 | $87 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Pfizer | 2 | $27 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Vertex | 1 | $16 |
| Merz Pharmaceuticals, LLC | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$2,411
- PROCLAIM$2,101
- SPECTRA WAVEWRITER$1,015
- WaveWriter Alpha Prime 16$105
How this compares
$9,980 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 12 | $35,620 |
| OxycontinOxycodone Hcl | 33 | $17,869 |
| Buprenorphine | 70 | $16,459 |
| QuliptaAtogepant | 12 | $12,557 |
| Xtampza ErOxycodone Myristate | 11 | $11,844 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 488 | $10,062 |
| Pregabalin | 191 | $9,408 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 253 | $8,096 |
| Tramadol Hcl ErTramadol Hcl | 103 | $8,015 |
| Oxycodone Hcl | 301 | $7,570 |
| Celecoxib | 84 | $5,467 |
| Fentanyl | 42 | $4,833 |
| Gabapentin | 278 | $3,891 |
| Hydromorphone Hcl | 85 | $1,974 |
| Tizanidine Hcl | 148 | $1,730 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $665 | $48,17724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Idaho Falls
- Amanda ThompsonIdaho Falls$67K
- Christina FinnertyIdaho Falls$10K
- Stephanie LeonardsonIdaho Falls$7K
- Christy TaylorIdaho Falls$6K
- Janet GarlandIdaho Falls$5K
- Rachel PetrusIdaho Falls$5K
- Victoria BlairIdaho Falls$5K
- Kylee JohnsonIdaho Falls$3K
- Brandee SimpsonIdaho Falls$3K
- Kathleen CliffordBoise$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.